financetom
Business
financetom
/
Business
/
Puma CEO: company 'well positioned' to cope with potential tariff increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Puma CEO: company 'well positioned' to cope with potential tariff increases
Nov 6, 2024 2:52 AM

(Reuters) - German sportswear maker Puma is well positioned to react swiftly to tariff increases, CEO Arne Freundt said on Wednesday, when asked about the potential impact of Donald Trump's plans to impose tariffs on some imports to the U.S.

Freundt said the multinational structure of the company's suppliers allow it to "quite easily" shift volumes from one country to another within the same supplier group when it sees duty increases in certain locations.

"We feel that for this volatile environment overall, we are very well positioned to react swiftly if certain tariffs are increasing in certain countries," he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Accolade Stock Trading Over 100% On Tuesday?
Why Is Accolade Stock Trading Over 100% On Tuesday?
Jan 8, 2025
Transcarent agreed to buy Accolade Inc Wednesday for $621 million. The purchase price works out to $7.03 per share in cash. Accolade is a Personalized Healthcare company that offers employer, health plan, and consumer solutions combined with virtual primary care and mental health, medical opinion, and care navigation. The transaction is expected to bring Transcarent’s generative AI-powered WayFinding and comprehensive care experiences —...
Why CureVac (CVAC) Stock Is Moving
Why CureVac (CVAC) Stock Is Moving
Jan 8, 2025
Shares of CureVac BV fell by 12.3% to $4.10 Wednesday afternoon. The pullback could be due to profit-taking after Tuesday's strong gains, which were fueled by heightened concerns over respiratory illnesses across the U.S. The surge in healthcare visits, driven by higher cases of seasonal influenza, COVID-19 and RSV, has renewed interest in vaccine and therapeutic manufacturers this week. Read...
Nordson Insider Sold Shares Worth $268,620, According to a Recent SEC Filing
Nordson Insider Sold Shares Worth $268,620, According to a Recent SEC Filing
Jan 8, 2025
01:37 PM EST, 01/08/2025 (MT Newswires) -- Stephen Lovass, Executive Vice President, on January 06, 2025, sold 1,299 shares in Nordson ( NDSN ) for $268,620. Following the Form 4 filing with the SEC, Lovass has control over a total of 7,546 shares of the company, with 7,347 shares held directly and 199 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/72331/000007233125000012/xslF345X05/wk-form4_1736361253.xml Price: 203.84,...
Jan 8, 2025
...
Copyright 2023-2026 - www.financetom.com All Rights Reserved